Order Article Reprints

De Leo A, de Biase D, Lenzi J, Barbero G, Turchetti D, Grillini M, Ravegnini G, Angelini S, Zamagni C, Coluccelli S, et al. ARID1A and CTNNB1/β-Catenin Molecular Status Affects the Clinicopathologic Features and Prognosis of Endometrial Carcinoma: Implications for an Improved Surrogate Molecular Classification. Cancers. 2021; 13(5):950. https://doi.org/10.3390/cancers13050950

De Leo, Antonio, Dario de Biase, Jacopo Lenzi, Giovanna Barbero, Daniela Turchetti, Marco Grillini, Gloria Ravegnini, Sabrina Angelini, Claudio Zamagni, Sara Coluccelli, and et al. 2021. "ARID1A and CTNNB1/β-Catenin Molecular Status Affects the Clinicopathologic Features and Prognosis of Endometrial Carcinoma: Implications for an Improved Surrogate Molecular Classification" Cancers 13, no. 5: 950. https://doi.org/10.3390/cancers13050950

De Leo, A., de Biase, D., Lenzi, J., Barbero, G., Turchetti, D., Grillini, M., Ravegnini, G., Angelini, S., Zamagni, C., Coluccelli, S., Dondi, G., De Iaco, P., Perrone, A. M., Tallini, G., Santini, D., & Ceccarelli, C. (2021). ARID1A and CTNNB1/β-Catenin Molecular Status Affects the Clinicopathologic Features and Prognosis of Endometrial Carcinoma: Implications for an Improved Surrogate Molecular Classification. Cancers, 13(5), 950. https://doi.org/10.3390/cancers13050950